Log in or Sign up for Free to view tailored content for your specialty!
Obesity News
SURMOUNT-3, keynote lectures highlight program at ObesityWeek
Experts in the field of obesity will gather in Dallas beginning on Saturday to hear about the latest research, discuss clinical practice recommendations and connect with colleagues at the ObesityWeek annual meeting.
Baseline glucose, increasing BMI predict progression to type 2 diabetes for children
Higher initial glucose levels and increasing BMI over time could serve as predictors of progression from prediabetes to type 2 diabetes for children and adolescents, according to findings published in the Journal of the Endocrine Society.
Log in or Sign up for Free to view tailored content for your specialty!
New anti-obesity medications: With great power comes great responsibility
Highly effective new anti-obesity medications such as semaglutide and tirzepatide have led to a sea change in expectations for the treatment of obesity, giving new hope to individuals who have struggled with excess weight for years.
Children with higher genetic risk for PCOS more likely to develop obesity
Children and adolescents with a high polygenic risk score for polycystic ovary syndrome tend to have a higher BMI and are more likely to develop obesity, according to study data.
Consider medications, surgery for long-term weight-loss success for midlife women
PHILADELPHIA — Midlife women with obesity should be counseled about anti-obesity medications and bariatric surgery in addition to diet, exercise and behavioral therapy for long-term weight-loss success, according to a speaker.
AHA highlights disease overlap with new term: Cardiovascular-kidney-metabolic syndrome
The American Heart Association unveiled a new term to reflect the interplay of several metabolic and renal conditions driving risk for CVD, along with an updated algorithm and guidance for screening, management and collaborative care.
VIDEO: Treating obesity first among key tips for physicians managing chronic diseases
ORLANDO — Physicians should be comfortable talking to patients about obesity and center their conversations around its health effects, according to a speaker at OMED.
Adults with obesity using tirzepatide maintain ‘remarkable’ weight loss at 88 weeks
Adults with obesity receiving tirzepatide lost more than 25% of their body weight and were able to maintain their weight loss for up to 88 weeks, according to data from the SURMOUNT-4 trial.
Slow walking pace, weight gain may be linked to CKD risk in adults with obesity
Slow walking pace and weight gain may be linked to chronic kidney disease risk in adults who have obesity but not diabetes, according to a study by Drexel University researchers.
New data links GLP-1 agonists for weight loss with higher risk for pancreatitis, GI events
Use of glucagon-like peptide 1 agonists for weight loss compared with bupropion-naltrexone was associated with an increased risk for pancreatitis, gastroparesis and bowel obstruction but not biliary disease, researchers reported in JAMA.
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read